Axelia Oncology
Melbourne
About Axelia Oncology
Axelia Oncology is a biopharmaceutical company aiming to transform the treatment of checkpoint-insensitive cancers by the activation of TLR2/6 engagement of the innate immune response.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $8.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2020)
- Website: axeliaoncology.com
- Phone: +61 3 9657 0700
Industries & Categories
Biopharma, Health Care, Health Diagnostics, Pharmaceutical
Canonical: https://fsome.com/organization/axelia-oncology-2415 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.